Atrial Fibrillation History Feature vs Reveal LINQ

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Atrial Fibrillation History Feature

by Apple Inc.

Reveal LINQ

by Medtronic

AI Verdict

Tool A is a consumer-grade wearable feature for retrospective AFib burden tracking and lifestyle correlation in diagnosed patients, not intended for real-time detection or continuous monitoring. Tool B is an implantable medical device designed for continuous, long-term cardiac monitoring to diagnose and manage various arrhythmias, including AFib. While both address AFib, their deployment, primary purpose (management vs. diagnosis/long-term monitoring), and HIPAA compliance make them suitable for distinct stages and needs in patient care.

Choose Atrial Fibrillation History Feature if…

Choose the Apple Atrial Fibrillation History Feature if you have a prior diagnosis of AFib and want to gain retrospective insights into your AFib burden and how lifestyle factors might influence it. This tool is ideal for proactive self-management and generating data to share with your physician for informed discussions about your treatment plan.

View Atrial Fibrillation History Feature →

Choose Reveal LINQ if…

Choose the Medtronic Reveal LINQ if you require long-term, continuous, and highly accurate ECG monitoring for the diagnosis of suspected but undiagnosed cardiac arrhythmias, cryptogenic stroke, or unexplained syncope. This implantable device provides up to three years of data, leveraging AI for precise detection, making it suitable for definitive clinical diagnosis under physician management.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Atrial Fibrillation History Feature	Reveal LINQ
Deployment	Mobile App	The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
BAA Available	No AI-estimated	Unknown
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	No AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Atrial Fibrillation History Feature

Tool A (Apple AFib History) offers superior usability from a patient's perspective, leveraging familiar consumer technology like the Apple Watch and iPhone Health app. Its non-invasive nature and direct access to personal health insights, along with easy PDF export for physicians, make it highly accessible for daily use. In contrast, Tool B (Reveal LINQ) is an implantable device requiring a medical procedure, making it less directly 'usable' by the patient in their daily life, with data primarily managed by clinicians.

Clinical Value

Reveal LINQ

Tool B (Reveal LINQ) provides significantly higher clinical value due to its continuous, long-term (up to three years) diagnostic-grade ECG monitoring. Its AccuRhythmu2122 AI algorithms accurately detect and diagnose various cardiac arrhythmias, including AFib, cryptogenic stroke, and unexplained syncope, offering critical diagnostic information. Tool A (Apple AFib History) is a retrospective tool for already diagnosed patients, providing insights into AFib burden and lifestyle correlations rather than real-time diagnosis.

Pricing & Value

Atrial Fibrillation History Feature

Tool A (Apple AFib History) offers exceptional value as it is included with a compatible Apple Watch purchase, incurring no additional cost for the feature itself. This makes it highly accessible for patients to gain insights into their AFib burden. Tool B (Reveal LINQ) is an implantable medical device with substantial associated costs for the device and procedure, typically covered by insurance, making its direct cost significantly higher.

Enterprise Readiness

Reveal LINQ

Tool B (Reveal LINQ) is designed for enterprise healthcare use, explicitly stating HIPAA compliance and implying a Business Associate Agreement (BAA) through its commitment to protecting Protected Health Information (PHI). It integrates into clinical workflows via the CareLink network and a clinician app. Tool A (Apple AFib History) is a consumer-facing feature lacking explicit HIPAA compliance or BAA, making it unsuitable for direct integration into enterprise healthcare systems for PHI management.

Innovation

Reveal LINQ

Tool B (Reveal LINQ) demonstrates a higher degree of innovation in medical device technology, being the world's smallest insertable cardiac monitor with continuous, long-term ECG recording and advanced AI algorithms for improved accuracy and reduced false alerts. This represents a significant advancement in diagnostic monitoring. While Tool A (Apple AFib History) innovatively applies existing wearable technology for consumer health insights, its core technology is more established.

Support & Docs

Tie

Both tools likely offer robust support and documentation tailored to their respective user bases. Tool A (Apple AFib History) benefits from Apple's extensive consumer support ecosystem and user-friendly digital documentation. Tool B (Reveal LINQ) is backed by Medtronic's specialized medical device support and comprehensive medical documentation for clinicians. Without specific comparative metrics on the quality or scope of support, it's difficult to definitively choose a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Atrial Fibrillation History Feature	Reveal LINQ
Name	Atrial Fibrillation History Feature	Reveal LINQ
Company	Apple	Medtronic
Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Wearables & Remote Monitoring (RPM)
Key Feature 1	Retrospective AFib burden estimation (weekly percentage)	World's smallest insertable cardiac monitor (1.2 mL)
Key Feature 2	Tracking and trending AFib burden over time	Continuous ECG monitoring for up to three years
Key Feature 3	Visualization of lifestyle factors (sleep, activity, alcohol, weight, mindful minutes) impacting AFib	AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause)

Videos

Demos, reviews, and walkthroughs featuring Atrial Fibrillation History Feature and Reveal LINQ.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental difference in how these tools monitor for atrial fibrillation?

Tool A (Apple's AFib History Feature) provides retrospective estimates of AFib burden and insights into lifestyle factors for diagnosed users. Tool B (Medtronic Reveal LINQ) offers continuous ECG monitoring for up to three years to detect and diagnose cardiac arrhythmias.

Are both tools cleared by the FDA, and what are their primary intended uses?

Yes, both Tool A and Tool B have FDA clearance. Tool A is intended for tracking AFib history and burden in previously diagnosed patients and is not for real-time detection or diagnosis. Tool B is for continuous ECG monitoring to detect and diagnose cardiac arrhythmias like AFib, cryptogenic stroke, and unexplained syncope.

Can either of these tools be used for the initial diagnosis of atrial fibrillation?

Tool A requires a prior physician diagnosis of AFib for activation and is not intended for real-time AFib detection or continuous monitoring, nor for diagnosis. Tool B, through its continuous ECG monitoring and AI algorithms, is designed to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, in patients with transient symptoms or at increased risk.

How do the AI capabilities of each tool differ?

Tool A's features visualize how lifestyle factors (sleep, activity, alcohol, weight, mindful minutes) may influence a diagnosed user's AFib condition. Tool B utilizes AccuRhythmu2122 AI algorithms specifically to accurately detect and diagnose cardiac arrhythmias, including AFib and pause, and to reduce false alerts.

What is the typical duration of monitoring provided by each tool?

Tool A provides weekly estimates and tracking of AFib burden over time, as long as the user wears the compatible Apple Watch. Tool B offers continuous ECG monitoring for an extended period of up to three years.